A comprehensive view of Merck KGaA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novo Nordisk, Lilly, Sanofi, Merck KGaA partner to recycle 25% of the 6 million insulin pens they sell in Denmark; the initiative aims to reclaim around 25 tons of plastic from the pens; 60% of which is high-quality plastic

Merck KGaA regains worldwide rights to cancer immunotherapy Bavencio, ending collaboration with Pfizer; 15% royalty on net sales to be paid to Pfizer.

Merck KGaA, Darmstadt, Germany and Intel Accelerate Sustainable Semiconductor Processes and Manufacturing Technologies Through Academic Research in Europe

Merck KGaA hands over IL-12-targeting cancer drug to PDS Biotech in deal worth over US$120.0M; the two companies are currently developing a triple combination immunotherapy to treat HPV-associated malignancies

Amgen, Merck KGaA sign separate deals to develop cancer-targeting antibody-drug conjugates with external drug developers in deals worth up to US$2.0B; Amgen partners with LegoChem Biosciences, Merck partners with Mersana Therapeutics

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count